# Heteroresistance associated with the production of fosfomycin-resistant inner colonies during disk diffusion testing among a geographically diverse collection of Klebsiella pneumoniae clinical isolates

**Authors:** Morgan L Bixby, Lindsey B Collins, Ellora C Daley, Jenna M Salay, Sofia Oliver, Alexandra L Bryson, Elizabeth B Hirsch

PMC · DOI: 10.1093/jacamr/dlaf013 · JAC-Antimicrobial Resistance · 2025-02-20

## TL;DR

This study finds that Klebsiella pneumoniae isolates producing inner colonies during fosfomycin disk diffusion tests often show higher resistance and heteroresistance, suggesting fosfomycin treatment should be avoided in such cases.

## Contribution

The study identifies a link between inner colony production and heteroresistance in K. pneumoniae, which is novel in fosfomycin resistance research.

## Key findings

- IC producers had 1.71 greater odds of heteroresistance compared to non-producers.
- IC isolates had significantly higher MICs than their parent isolates.
- No association was found between fosA presence and IC production or heteroresistance.

## Abstract

Fosfomycin susceptibility breakpoints apply only to Escherichia coli despite clinical use against Klebsiella pneumoniae. EUCAST and CLSI have different breakpoints and guidelines for disk diffusion (DD) interpretation that are frequently extrapolated to K. pneumoniae. Guidelines differ in interpreting inner colonies (IC) that grow within the zone of inhibition, but specificity to E. coli leaves knowledge gaps when extrapolating to other uropathogens.

To examine the frequency and MIC of K. pneumoniae IC during fosfomycin DD testing and to determine potential relationships between IC production, heteroresistance and fosA presence.

A collection of K. pneumoniae clinical isolates (n = 262) and their IC (n = 116) underwent broth microdilution testing. Heteroresistance screening and PCR for fosA was performed on susceptible isolates that either never produced (NP) IC (n = 14) or produced ≥5 resistant IC (n = 43).

The MIC range (≤2 to >256 mg/L) of clinical isolates increased to 32 to >1024 mg/L for the IC collection with a median MIC increase of three, 2-fold dilutions. IC producers had 1.71 greater odds (P < 0.01) of a positive heteroresistance screen compared to NP isolates. No relationship was found between fosA presence and either IC production or heteroresistance.

Production of ≥5 IC among clinical K. pneumoniae isolates was frequent and often resulted in an increased IC isolate MIC. Significantly greater odds of heteroresistance among IC producers were found when compared to NP isolates. Thus, presence of IC during fosfomycin DD testing should prompt avoidance of fosfomycin treatment.

## Linked entities

- **Genes:** fosA (glutathione transferase FosA (fosfomycin resistance protein)) [NCBI Gene 11637372]
- **Chemicals:** fosfomycin (PubChem CID 441029)
- **Species:** Klebsiella pneumoniae (taxon 573), Escherichia coli (taxon 562)

## Full-text entities

- **Genes:** fosA [NCBI Gene 7065654]
- **Chemicals:** Fosfomycin (MESH:D005578)
- **Species:** Klebsiella pneumoniae (species) [taxon 573], Escherichia coli (E. coli, species) [taxon 562]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11840249/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11840249/full.md

## References

49 references — full list in the complete paper: https://tomesphere.com/paper/PMC11840249/full.md

---
Source: https://tomesphere.com/paper/PMC11840249